Clinical Trials

Find a Trial

Trial Results

8 protocol(s) meet the specified criteria
APX-CLN-0011OPEN TO ACCRUAL
A Phase 1 Dose-escalation Study of APX3330 in Patients with Advanced Solid Tumors and a Dose-expansion Cohort of Patients with Advanced Ductal Adenocarcinoma of the Pancreas
ARRAY-162-202OPEN TO ACCRUAL
An Open-label Phase 1b/2 Study of Binimetinib Administered in Combination with Nivolumab or Nivolumab Plus Ipilimumab in Patients with Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer with RAS Mutation
CC9078OPEN TO ACCRUAL
Phase I/IB Multi-Center Study of Irreversible EGFR/HER2 Tyrosine Kinase Inhibitor Afatinib (BIBW2992)in Combination with Capecitabine for Advanced Solid Tumors and Pancretico- Biliary Cancers
GI15-225OPEN TO ACCRUAL
A Pilot Study of Pembrolizumab in Combination with Y90 Radioembolization in Subjects with Poor Prognosis Hepatocellular Carcinoma with Preserved Liver Function
INCB62079-101OPEN TO ACCRUAL
A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
IUSCC-0632OPEN TO ACCRUAL
Pilot Study to Examine Correlation of Nab-Paclitaxel/Gemcitabine Pharmacokinetics with Cachexia
LCCC1632OPEN TO ACCRUAL
LCCC 1632: Phase II multicenter trial of panitumumab, nivolumab, and ipilimumab for KRAS/NRAS/BRAF wild-type MSS refractory metastatic colorectal adenocarcinoma
NRG-GI004OPEN TO ACCRUAL
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer